Behemoth lab test company Quest Diagnostics is partnering with Google’s Fitbit to study how wearable technologies can improve metabolic health. The pilot study, dubbed Wearables for Metabolic Health (WEAR-ME), will combine Fitbit’s behavioral and biometric…
Continue Reading
A three-year collaboration integrates Lunit’s cutting-edge AI into Samsung’s premium X-ray devices, promising revolutionary enhancements in chest screening accuracy and speed. The partnership initially targets the US, Canada, and Europe, focusing on urgent medical…
Continue Reading
What You Should Know:
– Lunit, an innovator in AI-powered cancer diagnostics, and Samsung Electronics (Samsung Healthcare) have announced a groundbreaking three-year supply contract.
– The strategic partnership integrates Lunit’s cutting-edge AI technology into Samsung’s premium…
Continue Reading
Eisai’s collaboration with Oita University heralds a milestone in Alzheimer’s research, presenting an innovative AI model utilizing wearable device data for prediction. The study’s comprehensive approach, encompassing both biological and lifestyle data, results in…
Continue Reading
Are you a healthcare startup in health tech, diagnostics, medtech, or biotech? If so, you should consider applying to the MedCity News startup pitch contest at the INVEST conference at the Ritz Carlton in…
Continue Reading
What You Should Know:
– Veracyte, Inc. (Nasdaq: VCYT), a cancer diagnostics company acquires C2i Genomics, Inc., a pioneer in minimal residual disease (MRD) detection.
– Under the terms of the agreement, Veracyte will pay $70…
Continue Reading
What You Should Know: Ultima Genomics, a developer of a revolutionary new ultra-high throughput sequencing architecture, and Quest Diagnostics, the nation’s leading provider of diagnostic information services, today announced a collaboration involving Ultima’s next generation sequencing…
Continue Reading
What You Should Know:
– Goldman Sachs Asset Management has announced the closing of its first-ever life sciences fund, West Street Life Sciences I, surpassing its target with $650 million in commitments.
– This marks a…
Continue Reading
Penn Medicine’s iStar emerges as a game-changing AI tool, developed by Perelman School of Medicine experts. This revolutionary application, short for Inferring Super-Resolution Tissue Architecture, presents a paradigm shift in oncology diagnostics. iStar delves…
Continue Reading
Chaim Linhart, Chaim, Co-founder and CTO at Ibex Medical Analytics
Artificial intelligence (AI) technology is set to transform the field of diagnostics, similar to how X-rays and genetic tests revolutionized healthcare in the past. Reshaping…
Continue Reading
